Status:
COMPLETED
Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
Lead Sponsor:
Michelle Lofwall
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Withdrawal Syndrome
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
PHASE3
Brief Summary
Prescription opioid addiction is a growing public health problem and more pharmacologic treatments are needed because current approved medications have had limited patient acceptance (naltrexone), lim...
Eligibility Criteria
Inclusion
- Addicted to opioids
Exclusion
- Any major medical or psychiatric disorder that would be contraindicated for participation
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00980044
Start Date
October 1 2009
End Date
March 1 2012
Last Update
April 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40502